{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:36:27Z","timestamp":1790710587024,"version":"4.1.0"},"reference-count":115,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003391","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:18:21Z","timestamp":1069366701000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Antidepressants versus placebo for people with bulimia nervosa"],"prefix":"10.1002","volume":"2010","author":[{"given":"Josu\u00e9","family":"Bacaltchuk","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Department of Psychiatry; Rua Casa do Ator 764 apto 102 S\u00e3o Paulo - SP Brazil 04546-003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipa PJ","family":"Hay","sequence":"additional","affiliation":[{"name":"Building 3 ; Mental Health School of Medicine ; Campbelltown Campus University of Western Sydney Locked Bag 1797 Penrith South New South Wales Australia 2570"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,20]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1098-108X(198701)6:1<29::AID-EAT2260060105>3.0.CO;2-2","article-title":"Imipramine in the treatment of bulimia: a double-blind controlled study","volume":"6","author":"Agras","year":"1987","journal-title":"International Journal of Eating Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004850-200101000-00003","article-title":"Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial","volume":"16","author":"Carruba","year":"2001","journal-title":"International Journal of Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","article-title":"Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial","volume":"49","author":"Fluoxetine Bulimia Nervosa Collaborative Study Group","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1176\/ajp.150.5.770","article-title":"Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change","volume":"150","author":"Goldbloom","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1098-108X(199901)25:1<19::AID-EAT3>3.0.CO;2-3","article-title":"Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression","volume":"25","author":"Goldstein","year":"1999","journal-title":"International Journal of Eating Disorders"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1098-108X(199404)15:3<219::AID-EAT2260150304>3.0.CO;2-F","article-title":"Dissociation, childhood trauma, and the response to fluoxetine in bulimic patients","volume":"15","author":"McCarthy","year":"1994","journal-title":"International Journal of Eating Disorders"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0007|cit7","first-page":"235","article-title":"Lack of association between fluoxetine and suicidality in bulimia nervosa","volume":"53","author":"Wheadon","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004850-199300840-00014","article-title":"Pharmacotherapy of bulimia nervosa- experience with fluoxetine","volume":"8","author":"Wood","year":"1993","journal-title":"International Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0009|cit9","first-page":"262","article-title":"Treatment of bulimia with bupropion: a multicenter controlled trial","volume":"49","author":"Horne","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0010|cit10","first-page":"237","article-title":"Fluoxetine in the treatment of anxiety, depressive symptoms, and eating-related symptoms in bulimia nervosa","volume":"49","author":"Kanerva","year":"1994","journal-title":"Nordic Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003391-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004714-198812000-00002","article-title":"A trial of isocarboxazid in the treatment of bulimia nervosa","volume":"8","author":"Kennedy","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0278-5846(93)90057-Y","article-title":"The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa","volume":"17","author":"Davis","year":"1993","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD003391-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/BF00975048","article-title":"Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa","volume":"18","author":"Kennedy","year":"1993","journal-title":"Neurochemical Research"},{"issue":"6","key":"10.1002\/14651858.CD003391-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00004714-199312000-00007","article-title":"Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of braforamine","volume":"13","author":"Kennedy","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD003391-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1176\/ajp.147.11.1509","article-title":"Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study","volume":"147","author":"McCann","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004714-198408000-00003","article-title":"A placebo-controlled double-blind trial of amitriptyline in bulimia","volume":"4","author":"Mitchell","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/eat.10017","article-title":"Long-term impact of treatment in women diagnosed with bulimia nervosa","volume":"31","author":"Keel","year":"2002","journal-title":"International Journal of Eating Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.56.1.63","article-title":"Long-term outcome of bulimia nervosa","volume":"56","author":"Keel","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archpsyc.1990.01810140049008","article-title":"A comparison study of antidepressants and structured intensive group psychoterapy in the treatment of bulimia nervosa","volume":"47","author":"Mitchell","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003391-BIB0020|cit20","first-page":"128","article-title":"Manual-based self-help and fluoxetine in treating bulimia nervosa","volume":"12","author":"Mitchell","year":"1999","journal-title":"Current Opinion in Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00004714-200106000-00008","article-title":"The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa","volume":"21","author":"Mitchell","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0023|cit22","first-page":"339","article-title":"Antidepressant drug therapy for bulimia: current status","volume":"47","author":"Pope","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0022|cit23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ajp.140.5.554","article-title":"Bulimia treated with imipramine: a placebo-controlled, double-blind study","volume":"140","author":"Pope","year":"1983","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003391-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00004714-198505060-00003","article-title":"Antidepressant treatment of bulimia: A two-year follow-up study","volume":"5","author":"Pope","year":"1985","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003391-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002826-198901001-00007","article-title":"Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up","volume":"12","author":"Hudson","year":"1989","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00004714-198908000-00004","article-title":"A placebo-controlled study of trazodone in bulimia nervosa","volume":"9","author":"Pope","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E","article-title":"A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives","volume":"15","author":"Rothschild","year":"1994","journal-title":"International Journal of Eating Disorders"},{"key":"10.1002\/14651858.CD003391-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1192\/bjp.164.1.80","article-title":"Ten-year follow-up of 50 patients with bulimia nervosa","volume":"164","author":"Collings","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003391-BIB0029|cit29","first-page":"195","article-title":"Bulimia nervosa: a placebo-controlled double-blind therapeutic trial of mianserin","volume":"15 Suppl 2","author":"Sabine","year":"1983","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0030|cit30","first-page":"49","article-title":"A controlled trial of phenelzine in bulimia","volume":"23","author":"Walsh","year":"1987","journal-title":"Psychopharmacology Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1988.01800290091011","article-title":"Phenelzine vs placebo in 50 patients with bulimia","volume":"45","author":"Walsh","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD003391-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0022-3956(85)90058-5","article-title":"A double-blind trial of phenelzine in bulimia","volume":"19","author":"Walsh","year":"1985","journal-title":"Journal of Psychiatric Research"},{"issue":"11","key":"10.1002\/14651858.CD003391-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archpsyc.1983.01790220095015","article-title":"Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study","volume":"41","author":"Walsh","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0034|cit34","first-page":"90","article-title":"Personality disorder diagnoses in patients with bulimia nervosa. Clinical correlates and changes with treatment","volume":"53","author":"Ames-Frankel","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0306-4603(92)90044-V","article-title":"The impact of prior substance abuse on treatment outcome for bulimia nervosa","volume":"17","author":"Strasser","year":"1992","journal-title":"Addictive Behaviors"},{"issue":"9","key":"10.1002\/14651858.CD003391-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/ajp.148.9.1206","article-title":"Long-term outcome of antidepressant treatment for bulimia nervosa","volume":"148","author":"Walsh","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004714-199206000-00003","article-title":"Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa","volume":"12","author":"Walsh","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD003391-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1176\/appi.ajp.157.8.1332","article-title":"Fluoxetine for bulimia nervosa following poor response to psychotherapy","volume":"157","author":"Walsh","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003391-BIB0039|cit39","unstructured":"Walsh BT Agras WS Devlin MJ Kahn C Chally K Fluoxetine in bulimia following failure of psychotherapy 152nd Annual Meeting of the American Psychiatric Association. Washington DC, USA. 15 20th May 1999"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/0022-006X.70.2.267","article-title":"Cognitive-behavioral therapy for bulimia nervosa: Time course and mechanisms of change","volume":"70","author":"Wilson","year":"2002","journal-title":"Journal of Consulting & Clinical Psychology"},{"key":"10.1002\/14651858.CD003391-BIB0041|cit41","unstructured":"Goldstein DJ Wilson M Ascroft R Effectiveness of fluoxetine therapy in bulimia nervosa regardless of baseline depression 150th Annual Meeting of the American Psychiatric Association. San Diego, California, USA. 17 22 May 1997"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1098-108X(199901)25:1<19::AID-EAT3>3.0.CO;2-3","article-title":"Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression","volume":"25","author":"Goldstein","year":"1999","journal-title":"International Journal of Eating Disorders"},{"key":"10.1002\/14651858.CD003391-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1192\/bjp.166.5.660","article-title":"Long-term fluoxetine treatment of bulimia nervosa","volume":"166","author":"Goldstein","year":"1995","journal-title":"British Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0044|cit44","first-page":"235","article-title":"Lack of association between fluoxetine and suicidality in bulimia nervosa","volume":"53","author":"Wheadon","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.149.1.82","article-title":"Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison","volume":"149","author":"Agras","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0046|cit46","first-page":"179","article-title":"One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa","volume":"55","author":"Agras","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-1781(95)02681-L","article-title":"Comparing the cost effectiveness of psychiatric treatment: Bulimia nervosa","volume":"58","author":"Koran","year":"1995","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/1098-108X(199305)13:4<349::AID-EAT2260130403>3.0.CO;2-C","article-title":"Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa","volume":"13","author":"Rossiter","year":"1993","journal-title":"International Journal of Eating Disorders"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1037\/0022-006X.63.3.356","article-title":"Does interpersonal therapy help patients with binge eating disorder who fail to respond to cognitive-behavioral therapy?","volume":"63","author":"Agras","year":"1995","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD003391-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0005-7894(05)80285-0","article-title":"Weight loss, cognitive-behavioral, and desipramine treatments in binge eating disorder. An additive design","volume":"25","author":"Agras","year":"1994","journal-title":"Behavior Therapy"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/(SICI)1098-108X(199805)23:4<383::AID-EAT5>3.0.CO;2-E","article-title":"Patterns of interpersonal problems associated with binge eating disorder","volume":"23","author":"Eldredge","year":"1998","journal-title":"International Journal of Eating Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ajcn\/53.4.865","article-title":"Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects","volume":"53","author":"Alger","year":"1991","journal-title":"American Journal of Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/070674378803300211","article-title":"Treatment of bulimia with desipramine: a double-blind crossover study","volume":"33","author":"Barlow","year":"1988","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/070674378903400107","article-title":"Bulimia: Independence of antibulimic and antidepressant properties of desipramine","volume":"34","author":"Blouin","year":"1989","journal-title":"Canadian Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004714-198808000-00005","article-title":"Treatment of bulimia with fenfluramine and desipramine","volume":"8","author":"Blouin","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0056|cit56","first-page":"387","article-title":"Protriptyline weight loss in compulsive eaters: a placebo-controlled study","volume":"5","author":"Box","year":"1983","journal-title":"Journal of Psychiatric Treatment and Evaluation"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1014424","article-title":"Fluoxetine versus placebo: a double blind study with bulimic inpatients udergoing intensive psychotherapy","volume":"24","author":"Fichter","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD003391-BIB0060|cit58","unstructured":"Fichter MM Fluvoxamine in relapse prevention of bulimia nervosa Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans; LA, USA 2001"},{"key":"10.1002\/14651858.CD003391-BIB0061|cit59","unstructured":"Fichter MM Psychopharmacological relapse prevention and maintenance treatment of bulimia nervosa XXIst Collegium Internationale Neuro psychopharmacologicum, Glasgow, Scotland. 12th 16th July 1998"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0058|cit60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004714-199602000-00003","article-title":"Fluvoxamine in prevention of relapse in bulimia nervosa:effects on eating specific psychopathology","volume":"16","author":"Fichter","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0059|cit61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-979488","article-title":"Effects of fluvoxamine on depression, anxiety and other areas of general psychopathology in bulimia nervosa","volume":"30","author":"Fichter","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD003391-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Goldbloom D Garfinkel P Pharmacotherapy and psychotherapy in bulimia nervosa XXth Collegium Internationale Neuro psychopharmacologicum, Melbourne, Australia 1996","DOI":"10.1016\/0924-977X(96)88361-1"},{"issue":"9","key":"10.1002\/14651858.CD003391-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0005-7967(97)00041-7","article-title":"A randomized control trial of fluoxetine and cognitive behavioural therapy for bulimia nervosa: short-term outcome","volume":"35","author":"Goldbloom","year":"1997","journal-title":"Behavioral Research and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0064|cit64","first-page":"188","article-title":"Therapeutic effectiveness of bupropion for bulimia: a possible artifact","volume":"50","author":"Hahn","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.1986.01800020092012","article-title":"Treating bulimia with desipramine. A double-blind, placebo-controlled study","volume":"43","author":"Hughes","year":"1986","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003391-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1176\/ajp.143.11.1495a","article-title":"Isocarboxazid in the treatment of bulimia","volume":"143","author":"Kennedy","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003391-BIB0067|cit67","doi-asserted-by":"crossref","unstructured":"Koran L McElroy S Davidson J Rasmussen S Hollander E Jenike M Double-blind comparison of fluvoxamine and clomipramine in obsessive compulsive disorder in the United States 8th ECNP (European College of Neuropsychopharmacology) Congress, Venice, Italy 1995","DOI":"10.1016\/0924-977X(95)90658-Z"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004714-199604000-00004","article-title":"Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison","volume":"16","author":"Koran","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0005-7967(94)90082-5","article-title":"Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa","volume":"32","author":"Leitenberg","year":"1994","journal-title":"Behaviour Research and Therapy"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.147.7.876","article-title":"A double-blind placebo-controlled trial of fluoxetine plus behavioral modification in the treatment of obese binge-eaters","volume":"147","author":"Marcus","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2190\/H4RN-EC2M-WJNX-U0X6","article-title":"A study of drop-outs in psychopharmacological research with bulimics","volume":"16","author":"Margittai","year":"1987","journal-title":"International Journal of Psychiatry in Medecine"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0072|cit72","first-page":"41","article-title":"Antidepressants vs group therapy in the treatment of bulimia","volume":"23","author":"Mitchell","year":"1987","journal-title":"Psychopharmacology Bulletin"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1176\/ajp.147.7.871","article-title":"Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment","volume":"147","author":"Pyle","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD003391-BIB0074|cit74","first-page":"385","article-title":"Antidepressant drug therapy for bulimia: current status revisited","volume":"48","author":"Price","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003391-BIB0075|cit75","unstructured":"Beumont P Russell J Tobyz S Johnson G Fluoxetine and nutritional counselling in bulimia nervosa Xth World Congress of Psychiatry, Madrid, Spain 1996"},{"key":"10.1002\/14651858.CD003391-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"Beumont P Russell J Touyz S Johnson G Fluoxetine and intensive nutritional counselling in the treatment of bulimia nervosa XXth Collegium Internationale Neuro psychopharmacologicum, Melbourne, Australia 1996","DOI":"10.1016\/0924-977X(96)88360-X"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/00048679709065073","article-title":"Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?","volume":"31","author":"Beumont","year":"1997","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003391-BIB0078|cit78","doi-asserted-by":"crossref","unstructured":"Russell J Beumont P Touyz S Buckley C Lowinger K Talbot P The effects of fluoxetine in patients receiving nutritional counselling for bulimia nervosa 8th ECNP (European College of Neuropsychopharmacology) Congress, Venice, Italy 1995","DOI":"10.1016\/0924-977X(96)88360-X"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0079|cit79","first-page":"171","article-title":"Fluoxetine in the pharmacological treatment of bulimia nervosa","volume":"29","author":"Scrimali","year":"1994","journal-title":"Rivista di Psichiatria"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0080|cit80","first-page":"49","article-title":"A controlled trial of phenelzine in bulimia","volume":"23","author":"Walsh","year":"1987","journal-title":"Psychopharmacology Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1988.01800290091011","article-title":"Phenelzine vs placebo in 50 patients with bulimia","volume":"45","author":"Walsh","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD003391-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0022-3956(85)90058-5","article-title":"A double-blind trial of phenelzine in bulimia","volume":"19","author":"Walsh","year":"1985","journal-title":"Journal of Psychiatric Research"},{"issue":"11","key":"10.1002\/14651858.CD003391-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archpsyc.1983.01790220095015","article-title":"Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study","volume":"41","author":"Walsh","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004714-199206000-00003","article-title":"Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa","volume":"12","author":"Walsh","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/ajp.154.4.523","article-title":"Medication and psychotherapy in the treatment of bulimia nervosa","volume":"154","author":"Walsh","year":"1997","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003391-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1037\/0022-006X.67.4.451","article-title":"Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change","volume":"67","author":"Wilson","year":"1999","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0149-7634(94)00044-2","article-title":"Pharmacotherapy of the eating disorders: a commentary","volume":"19","author":"Advokat","year":"1995","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1002\/14651858.CD003391-BIB0088|cit88","volume-title":"Diagnostic and Statistics Manual of mental disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD003391-BIB0089|cit89","volume-title":"Diagnostic and Statistics Manual of mental disorders (DSM-III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD003391-BIB0090|cit90","volume-title":"Diagnostic and Statistics Manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0091|cit91","article-title":"Antidepressants versus psychological treatments and their combination for bulimia nervosa","author":"Bacaltchuk","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD003391-BIB0092|cit92","unstructured":"Buchan IE Arcus QuickStat Biomedical for windows 1998"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0093|cit93","first-page":"133","article-title":"Pharmacological treatment of bulimia","volume":"22","author":"Corcos","year":"1996","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD003391-BIB0094|cit94","volume-title":"Meta-analyse des essais therapeutiques","author":"Cucherat","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004714-199602000-00003","article-title":"Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating specific psychopathology","volume":"6","author":"Fichter","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD003391-BIB0097|cit97","first-page":"0","article-title":"Bulimia Nervosa","volume":"5","author":"Hay","year":"2001","journal-title":"Clinical Evidence"},{"key":"10.1002\/14651858.CD003391-BIB0098|cit98","volume-title":"Statistical methods for meta-analysis","author":"Hedges","year":"1985"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003391-BIB0100|cit100","volume-title":"The etiology and treatment of bulimia nervosa","author":"Johnson","year":"1994"},{"key":"10.1002\/14651858.CD003391-BIB0101|cit101","doi-asserted-by":"crossref","DOI":"10.4159\/9780674040243","volume-title":"Summing up: The Science of Revieweing Research","author":"Light","year":"1984"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0102|cit102","article-title":"A comparison of drugs versus placebo for the treatment of dysthymia: a systematic review","author":"Lima","year":"1998","journal-title":"Cochrane Library"},{"key":"10.1002\/14651858.CD003391-BIB0103|cit103","article-title":"Cochrane Collaboration Handbook","volume-title":"Cochrane Library","author":"Mulrow","year":"1996"},{"key":"10.1002\/14651858.CD003391-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1037\/0033-2909.86.3.638","article-title":"The \"file drawer problem\" and the tolerance for null results","volume":"86","author":"Rosenthal","year":"1979","journal-title":"Psychological Bulletin"},{"key":"10.1002\/14651858.CD003391-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S0033291700031974","article-title":"Bulimia Nervosa: an ominous variant of anorexia nervosa","volume":"9","author":"Russell","year":"1979","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD003391-BIB0106|cit106","first-page":"11","article-title":"The history of bulimia nervosa","volume-title":"Handbook of treatment for eating disorders","author":"Russell","year":"1997"},{"key":"10.1002\/14651858.CD003391-BIB0107|cit107","volume-title":"Cochrane Collaboration Handbook","author":"Sackett","year":"1994"},{"key":"10.1002\/14651858.CD003391-BIB0108|cit108","volume-title":"Evidence-based medicine. How to practice and teach EBM","author":"Sackett","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD003391-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schultz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003391-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1098-108X(199009)9:5<545::AID-EAT2260090510>3.0.CO;2-Z","article-title":"Problems of research on eating disorders","volume":"5","author":"Shaw","year":"1990","journal-title":"International Journal of Eating Disorders"},{"key":"10.1002\/14651858.CD003391-BIB0111|cit111","first-page":"48","article-title":"Why sources of heterogeneity in meta-analysis should be investigated","volume-title":"Systematic Reviews","author":"Thomson","year":"1995"},{"issue":"7","key":"10.1002\/14651858.CD003391-BIB0112|cit112","first-page":"235","article-title":"Lack of an association between fluoxetine and suicidality in bulimia nervosa","volume":"53","author":"Wheadon","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003391-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1098-108X(199807)24:1<13::AID-EAT2>3.0.CO;2-3","article-title":"The clinical utility of randomized controlled trials","volume":"24","author":"Wilson","year":"1998","journal-title":"International Journal of Eating Disorders"},{"issue":"3","key":"10.1002\/14651858.CD003391-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0883-9417(95)80033-6","article-title":"Dimensions of response to antidepressant in bulimia nervosa: a review","volume":"9","author":"Wolfe","year":"1995","journal-title":"Archives of Psychiatric Nursing"},{"issue":"2","key":"10.1002\/14651858.CD003391-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/j.1440-1614.2000.00709.x","article-title":"Antidepressants versus placebo for the treatment of bulimia nervosa: a systematic review","volume":"34","author":"Bacaltchuk","year":"2000","journal-title":"Australian and New Zealand Journal of Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003391\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T18:31:35Z","timestamp":1753122695000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003391"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,10,20]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003391","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,20]]}}}